Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 106 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase II-III Vindesine Therapy by Single Dose vs Continuous Infusion for Refractory Metastatic Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified								MDA-MBDT-7848


2.		Phase II/III Chemotherapy with Continuous 5-Day Vindesine Infusion for Metastatic Renal Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				no age specified								MDA-DT-7913


3.		Phase II/III cis-Platinum in 2-Drug and 3-Drug Combinations with VP-16 and DAVA for Advanced non-Oat Cell Carcinoma of the Lung

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified								MDA-DT-8075 NCI-D81-043-098


4.		Phase II/III Chemotherapy with CAMP (CTX/ADR/MTX/PCB) vs VP-16/DAVA/CACP vs VP-16/CACP vs DAVA/CACP for Stage III Metastatic non-Small Cell Bronchogenic Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				under 70								UCCRC-3248 NCI-D81-014-080


5.		Phase II/III Randomized Comparison of Combination Chemotherapy with CACP/DAVA plus Split-Course Radiotherapy vs Radiotherapy Alone for Localized Nonresectable non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				70 and under								EORTC-08842

Last Modified: 3/3/2005


6.		Phase III Randomized Study of Adjuvant MVP (MITO/DAVA/CDDP) vs No Adjuvant Chemotherapy (with or without Adjuvant Radiotherapy) for Radically Resected Stage I/II/IIIA non-Small Cell Lung Cancer (Summary Last Modified 06/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 to 70								CNR-ALPI EORTC-08952, EU-94043


7.		Phase III Comparison of 5-Day Continuous Infusions of DAVA vs VBL vs VCR for Metastatic Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								MDA-MBDT-8008

Last Modified: 5/8/2007


8.		Phase III Nonrandomized Study of Therapy Based on Risk Group for Children and Adolescents with Neuroblastoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				under 21								GER-NB90 EU-96004, NCT00002802

Last Modified: 7/26/2007


9.		Phase III Randomized Study of Adjuvant Chemotherapy Following Curative Resection for non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 to 75				Other				FRE-IALT EU-96010, NCT00002823

Last Modified: 8/1/2001 First Published: 3/1/1998


10.		Phase III Study of Radiotherapy With or Without Chemotherapy as Adjuvant Treatment for Patients with Node Positive Stage IB or IIA Cervical Cancer (Summary Last Modified 08/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over								EORTC-55954 MRC-CE04, COSA, EU-98061, NSGO-CC-9502, NCT00003209

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute